stockrowAdaptive Biotechnologies Corporation (ADPT) vs BillionToOne, Inc. (BLLN)
- Adaptive Biotechnologies Corporation ADPT 26.96 +0.94%
- BillionToOne, Inc. BLLN 111.96 −1.69%
Adaptive Biotechnologies Corporation and BillionToOne, Inc. are both Diagnostics & Research companies. BillionToOne, Inc. is the larger, with a market value of $5.3B against $4.3B — 1.2× the size. Adaptive Biotechnologies Corporation has negative trailing earnings, so its P/E is not meaningful; BillionToOne, Inc. trades at 88.7×. BillionToOne, Inc. grew revenue faster over the last twelve months: 76.5% against 17.9%. BillionToOne, Inc. has the higher net margin (11.2% vs −23.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, BillionToOne, Inc. leads on 14 and Adaptive Biotechnologies Corporation on 1.
Valuation
Profitability
| Metric | ADPT | BLLN | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 74.15% | 71.41% | 48.32% |
| Operating margin | (16.18%) | 10.23% | (5.68%) |
| Net margin | (23.66%) | 11.23% | (4.10%) |
| Free cash flow margin | (2.96%) | 7.76% | 0.00% |
| Return on equity | (36.34%) | 0.00% | 0.00% |
| Return on assets | (12.02%) | 9.02% | (6.05%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack